The slow intravenous infusion protocols used in clinical trials minimized these effects, suggesting that rapid bolus administration (which is essentially what subcutaneous injection creates) may increase the likelihood of transient side effects
Each peptide is supplied in individual 5mg vials to allow flexible experimental design and improved peptide stability
Not approved for children
These products are not drugs, foods, cosmetics, or dietary supplements, have not been evaluated by the FDA, and are not intended for human or animal use
According to the Journal of therapeutic Investigation, GLP-1 medications have therapeutic effects even in those who do not significantly lose weight, highlighting their direct anti-inflammatory and anti-fibrotic mechanisms
Circulation (2014) 129(5):58797